Page last updated: 2024-09-03

fosamprenavir and maraviroc

fosamprenavir has been researched along with maraviroc in 3 studies

Compound Research Comparison

Studies (fosamprenavir)	Trials (fosamprenavir)	Recent Studies (post-2010) (fosamprenavir)	Studies (maraviroc)	Trials (maraviroc)	Recent Studies (post-2010) (maraviroc)
174	55	37	785	124	539

Protein Interaction Comparison

Protein	Taxonomy	maraviroc (IC50)
Cytochrome P450 3A4	Homo sapiens (human)	3.1
Delta-type opioid receptor	Rattus norvegicus (Norway rat)	0.0014
C-C chemokine receptor type 5	Homo sapiens (human)	0.0044
C-C chemokine receptor type 5	Mus musculus (house mouse)	0.0052

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Degli Antoni, A; Ferrari, C; Fragola, V; Manfredi, R; Weimer, LE	1
Fang, A; Heera, J; Mendes da Costa, L; Plotka, A; Vourvahis, M	1

Reviews

1 review(s) available for fosamprenavir and maraviroc

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for fosamprenavir and maraviroc

Article	Year
Pharmacokinetic interaction between maraviroc and fosamprenavir-ritonavir: an open-label, fixed-sequence study in healthy subjects. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:12 Topics: Adult; Anti-HIV Agents; Area Under Curve; Carbamates; Cyclohexanes; Drug Administration Schedule; Drug Combinations; Drug Dosage Calculations; Drug Interactions; Furans; Humans; Male; Maraviroc; Middle Aged; Organophosphates; Ritonavir; Sulfonamides; Triazoles	2013

Article

Year

Pharmacokinetic interaction between maraviroc and fosamprenavir-ritonavir: an open-label, fixed-sequence study in healthy subjects.

Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:12

Topics: Adult; Anti-HIV Agents; Area Under Curve; Carbamates; Cyclohexanes; Drug Administration Schedule; Drug Combinations; Drug Dosage Calculations; Drug Interactions; Furans; Humans; Male; Maraviroc; Middle Aged; Organophosphates; Ritonavir; Sulfonamides; Triazoles

2013

Other Studies

1 other study(ies) available for fosamprenavir and maraviroc

Article	Year
A reduced grade of liver fibro-steatosis after raltegravir, maraviroc and fosamprenavir in an HIV/HCV co-infected patient with chronic hepatitis, cardiomyopathy, intolerance to nelfinavir and a marked increase of serum creatine phosphokinase levels probab The West Indian medical journal, 2012, Volume: 61, Issue:9 Topics: Adult; Carbamates; Cardiomyopathies; Chemical and Drug Induced Liver Injury; Creatine Kinase; Cyclohexanes; Drug Substitution; Drug Therapy, Combination; Fatty Liver; Furans; Hepatitis C, Chronic; HIV Fusion Inhibitors; HIV Infections; HIV Integrase Inhibitors; HIV Protease Inhibitors; Humans; Liver Cirrhosis; Male; Maraviroc; Organophosphates; Pyrrolidinones; Raltegravir Potassium; Sulfonamides; Triazoles	2012

Article

Year

A reduced grade of liver fibro-steatosis after raltegravir, maraviroc and fosamprenavir in an HIV/HCV co-infected patient with chronic hepatitis, cardiomyopathy, intolerance to nelfinavir and a marked increase of serum creatine phosphokinase levels probab

The West Indian medical journal, 2012, Volume: 61, Issue:9

Topics: Adult; Carbamates; Cardiomyopathies; Chemical and Drug Induced Liver Injury; Creatine Kinase; Cyclohexanes; Drug Substitution; Drug Therapy, Combination; Fatty Liver; Furans; Hepatitis C, Chronic; HIV Fusion Inhibitors; HIV Infections; HIV Integrase Inhibitors; HIV Protease Inhibitors; Humans; Liver Cirrhosis; Male; Maraviroc; Organophosphates; Pyrrolidinones; Raltegravir Potassium; Sulfonamides; Triazoles

2012